Aphria Inc (NYSE:APHA)’s share price traded up 8% on Tuesday . The stock traded as high as $9.20 and last traded at $9.05. 9,937,906 shares were traded during trading, an increase of 9% from the average session volume of 9,121,452 shares. The stock had previously closed at $8.38.

A number of brokerages have recently commented on APHA. Eight Capital downgraded Aphria to a “hold” rating and set a $7.00 price objective for the company. in a research report on Thursday, December 13th. Canaccord Genuity reissued a “buy” rating on shares of Aphria in a report on Wednesday, December 5th. CIBC began coverage on Aphria in a report on Friday, January 18th. They issued a “neutral” rating for the company. Finally, Cormark set a $15.00 target price on Aphria and gave the stock a “buy” rating in a research report on Saturday, February 2nd.

The firm has a market cap of $2.28 billion and a PE ratio of 104.78.

Aphria (NYSE:APHA) last issued its quarterly earnings results on Friday, January 11th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $16.58 million for the quarter.

A number of institutional investors and hedge funds have recently made changes to their positions in APHA. Winslow Evans & Crocker Inc. acquired a new position in Aphria in the 4th quarter valued at approximately $28,000. Intercontinental Wealth Advisors LLC purchased a new stake in Aphria during the fourth quarter worth about $28,000. 1832 Asset Management L.P. purchased a new stake in Aphria during the fourth quarter worth about $50,000. Wedbush Securities Inc. purchased a new position in shares of Aphria in the fourth quarter worth about $66,000. Finally, M&T Bank Corp purchased a new position in shares of Aphria in the fourth quarter worth about $68,000. Institutional investors and hedge funds own 1.48% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://www.watchlistnews.com/aphria-apha-trading-8-higher/2821274.html.

Aphria Company Profile (NYSE:APHA)

Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.

Featured Story: What is a Candlestick Chart?

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.